HC Wainwright & Co. Reiterates Buy on Eton Pharmaceuticals, Raises Price Target to $15

Benzinga · 11/26 11:47
HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Eton Pharmaceuticals (NASDAQ:ETON) with a Buy and raises the price target from $11 to $15.